Who We Are
Since our establishment in 1995, we have successfully conducted over 200 psychiatric clinical trials in collaboration with leading pharmaceutical companies. This has enabled us to bring new and improved treatment options closer to those who need them most, with a focus on safety and efficacy in our research efforts.
By conducting over 200 clinical trials since 1995, we contribute significantly to the safe and effective evaluation of new or existing medications, enhancing mental health care and ensuring adherence to FDA requirements.
Our Mission
Our mission is to light the way in clinical research, placing compassion, safety, and participant well-being at the heart of our endeavors. We are committed to advancing innovative clinical trials with the utmost standards of quality, ethics, and patient care. We are dedicated to improving global health outcomes through ethical clinical research practices.
Our commitment is to uphold the highest standards of quality and ethics in clinical research. We prioritize participant care and well being in every study we undertake, ensuring that our research contributes positively to the advancement of global health.
Clinical Trials We Offer
We conduct various clinical trials, including those focused on ADHD, Anxiety, Bipolar Disorder, Borderline Personality Disorder, Depression, PTSD and Binge Eating Disorder. These trials are designed to evaluate the safety and effectiveness of new or existing medications, providing critical data needed for their approval and use. Participants are carefully monitored throughout the study to ensure accurate and reliable results.
These studies are carefully designed to evaluate treatment options, providing participants with an opportunity to contribute to advancements in these areas while receiving close medical monitoring.
